Free press releases distribution network?

Agency / Source: Wiltshire Capital

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



The Biotechnology Market to Reach $275M by 2012 Finds Wiltshire Capital - In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007
The Biotechnology Market to Reach $275M by 2012 Finds Wiltshire Capital

 

PRZOOM - /newswire/ - Nishi-Shinjuku, Tokyo, Japan, 2011/05/04 - In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The biotechnology market is an ever-expanding, demanding, and lucrative market. Areas of the biotechnology market include; agriculture GMO, antibody technologies, antisense technology, biomaterials, biopharmaceuticals, drug discovery, emerging technology, environmental/industrial biotechnology, enzymes, gene therapy, general biotechnology, genetic engineering, genomics, informatics, instrumentation and equipment, molecular biology, pharmaceuticals, proteomics, regulation and bioethics, research and development, tissue engineering and wound care.

In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007. In value terms, the medical/healthcare segment generated 69.4% of the global biotechnology market value.

Malaysia has emerged as a major investment destination for biotech companies. The Malaysian biotech market posted high growth last year and is expected to do the same in next few years. Rich biodiversity, availability of low cost human resources and strong government efforts are some of the reasons that have boosted growth in the market. The biotech market in Malaysia is expected to grow around 21% during 2010-2012.

Wiltshire Capital (witshirecapital.com) has studied the Malaysian biotech market by breaking it into three segments – healthcare biotech, agriculture biotech and industrial biotech. Each of these segments has been extensively covered, giving in-depth analysis of the current and future market trends along with valuable data of past trends. The report also provides a complete overview of regulatory environment for the biotech market.

Wiltshire Capital’s report has found that increasing prevalence of diseases and rising exports of drugs from Malaysia are driving growth in the healthcare biotechnology market. This segment holds the highest potential for growth and will post the fastest growth rate among all the three segments.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Wiltshire Capital

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


The Biotechnology Market to Reach $275M by 2012 Finds Wiltshire Capital

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Kaito Hiroshi - WiltshireCapital.com 
+81 345-790199 pr[.]wiltshirecapital.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Wiltshire Capital securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Wiltshire Capital / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  Intrinsic Executive Search Ltd

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today